sequencing first-line cdk4/6 inhibitors in metastatic breast cancer
Published 4 months ago • 137 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
8:30
cdk4/6 inhibitors in er metastatic breast cancer during the covid-19 pandemic
-
3:57
cdk 4/6 inhibitor as first-line therapy for advanced breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
3:50
cdk4/6 inhibitors in metastatic breast cancer
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
5:34
cdk4/6 inhibitors in metastatic breast cancer
-
5:38
cdk4/6 inhibitors in metastatic breast cancer
-
6:11
hr metastatic breast cancer: upfront cdk4/6 inhibition
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
3:38
mbc: cdk4/6 inhibitor patient selection/sequencing
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices